Hall A1 - Room 16 Industry Satellite Symposium

MSD - Checkpoint inhibition in the treatment of cancer: Building the new standard of care across multiple solid tumours and understanding the role of pembrolizumab

Location
Hall A1 - Room 16
Date
19.10.2018
Time
18:00 - 20:00
Chairs
  • E. Van Cutsem
18:00 - 18:10 Industry Satellite Symposium Presentation MSD - Checkpoint inhibition in the treatment of cancer: Building the new standard of care across multiple solid tumours and understanding the role of pembrolizumab Industry Satellite Symposium
  • E. Van Cutsem

Introduction: Welcome & opening

Presentation Topic
Industry Satellite Symposium Presentation
Lecture Time
18:00 - 18:10
Duration
10 Minutes
Session Name
MSD - Checkpoint inhibition in the treatment of cancer: Building the new standard of care across multiple solid tumours and understanding the role of pembrolizumab
Location
Hall A1 - Room 16, ICM München, Munich, Germany
Date
19.10.2018
Time
18:00 - 20:00
Speakers
  • E. Van Cutsem
18:10 - 18:30 Industry Satellite Symposium Presentation MSD - Checkpoint inhibition in the treatment of cancer: Building the new standard of care across multiple solid tumours and understanding the role of pembrolizumab Industry Satellite Symposium
  • R. Dummer

Checkpoint inhibitors across melanoma landscape

Presentation Topic
Industry Satellite Symposium Presentation
Lecture Time
18:10 - 18:30
Duration
20 Minutes
Session Name
MSD - Checkpoint inhibition in the treatment of cancer: Building the new standard of care across multiple solid tumours and understanding the role of pembrolizumab
Location
Hall A1 - Room 16, ICM München, Munich, Germany
Date
19.10.2018
Time
18:00 - 20:00
Speakers
  • R. Dummer
18:30 - 18:50 Industry Satellite Symposium Presentation MSD - Checkpoint inhibition in the treatment of cancer: Building the new standard of care across multiple solid tumours and understanding the role of pembrolizumab Industry Satellite Symposium
  • E. Van Cutsem

Treatment of GI cancers with checkpoint inhibitors: Are we on the edge of a new era?

Presentation Topic
Industry Satellite Symposium Presentation
Lecture Time
18:30 - 18:50
Duration
20 Minutes
Session Name
MSD - Checkpoint inhibition in the treatment of cancer: Building the new standard of care across multiple solid tumours and understanding the role of pembrolizumab
Location
Hall A1 - Room 16, ICM München, Munich, Germany
Date
19.10.2018
Time
18:00 - 20:00
Speakers
  • E. Van Cutsem
18:50 - 19:10 Industry Satellite Symposium Presentation MSD - Checkpoint inhibition in the treatment of cancer: Building the new standard of care across multiple solid tumours and understanding the role of pembrolizumab Industry Satellite Symposium
  • E. Yu

Checkpoint inhibition for the treatment of genitourinary cancers

Presentation Topic
Industry Satellite Symposium Presentation
Lecture Time
18:50 - 19:10
Duration
20 Minutes
Session Name
MSD - Checkpoint inhibition in the treatment of cancer: Building the new standard of care across multiple solid tumours and understanding the role of pembrolizumab
Location
Hall A1 - Room 16, ICM München, Munich, Germany
Date
19.10.2018
Time
18:00 - 20:00
Speakers
  • E. Yu
19:10 - 19:30 Industry Satellite Symposium Presentation MSD - Checkpoint inhibition in the treatment of cancer: Building the new standard of care across multiple solid tumours and understanding the role of pembrolizumab Industry Satellite Symposium
  • H. McArthur

Emergent women’s cancers therapies: Catalyst to transform standard of care

Presentation Topic
Industry Satellite Symposium Presentation
Lecture Time
19:10 - 19:30
Duration
20 Minutes
Session Name
MSD - Checkpoint inhibition in the treatment of cancer: Building the new standard of care across multiple solid tumours and understanding the role of pembrolizumab
Location
Hall A1 - Room 16, ICM München, Munich, Germany
Date
19.10.2018
Time
18:00 - 20:00
Speakers
  • H. McArthur
19:30 - 20:00 Industry Satellite Symposium Presentation MSD - Checkpoint inhibition in the treatment of cancer: Building the new standard of care across multiple solid tumours and understanding the role of pembrolizumab Industry Satellite Symposium
  • E. Van Cutsem

Conclusions: Panel discussion / Q&A / Closing

Presentation Topic
Industry Satellite Symposium Presentation
Lecture Time
19:30 - 20:00
Duration
30 Minutes
Session Name
MSD - Checkpoint inhibition in the treatment of cancer: Building the new standard of care across multiple solid tumours and understanding the role of pembrolizumab
Location
Hall A1 - Room 16, ICM München, Munich, Germany
Date
19.10.2018
Time
18:00 - 20:00
Speakers
  • E. Van Cutsem